Gabapentin Capsule
Product Images NDC 68788-7838

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-7838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Capsules, Usp 400mg

This is a description of Gabapentin capsules, USP 400mg. The capsules are generic for Neurontin. Each capsule contains 400mg of Gabapentin. The product is manufactured by ScieGen Pharmaceuticals, Inc, and the product code is ENeo. The description includes batch and lot numbers but does not include instructions for use. Caution is stated regarding federally-prohibited transfer of the capsules.*

FDA Label Image

Figure 1 (Image 01)

This appears to be a table with columns representing different treatment options for pain management, including a fixed dose and a dose that is titrated (adjusted over time). The different treatment options may include a placebo or gabapentin at 3600 mg/day. The table also includes a baseline measurement and pain scores measured at different time points (weeks).*

FDA Label Image

Figure 2 (Image 02)

This appears to be a chart showing the results of a study evaluating the use of Gabapentin (at varying dosages) versus a placebo for pain management over a four-week period. The X-axis represents the weeks of the study and the Y-axis represents the mean pain score reported by participants. However, without further context or information, it is difficult to provide a more specific description or interpretation.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.